XBIO Xenetic Biosciences: Utang jangka cendhak perusahaan

Simbol lan logo merek Xenetic Bio (XBIO)

Xenetic Biosciences (XBIO) develops anti-tumor delivery systems, generating revenue through long-term licenses and royalties. Patents create a defensive moat for the business, although success depends on FDA approval. The price action of securities with the 0.00 metric is shown below. The asset is not subject to inflation, as quotes are determined exclusively by medical test results and stable demand for therapy.

XBIO Silihan lan utang jangka cendhak perusahaan xeneticbio.com (04.07.2022 - 01.11.2026)
Produk sing diprodhuksi Xenetic Biosciences

This indicator measures obligations with a maturity of up to one year, determining short-term solvency and the risk of liquidity loss. The trend in current liabilities reflects the financial stability of Xenetic Biosciences (XBIO), as a high dependence on external CROs and outsourced clinical trials requires a constant availability of free cash to fund contracts.

Perusahaan pesaing

BeiGene - Utang jangka cendhak perusahaan|Halozyme Therapeutics, Inc. (HALO) - Kewajiban jangka cendhak perusahaan|RVMD: Utang jangka cendhak perusahaan|Utang jangka cendhak Ascentage Pharma Corp (AAPG)|Utang jangka cendhak perusahaan CG Oncology, Inc.|URGN: Silihan lan utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ERAS (Erasca Corp)|DCTH - Kewajiban jangka cendhak perusahaan|YMAB: Kewajiban jangka cendhak perusahaan|AURA - Utang jangka cendhak perusahaan|candeltx.com (CADL) - Utang jangka cendhak perusahaan|Accuray Inc - Silihan lan utang jangka cendhak perusahaan|SLS (SELLAS Life Sciences Group, Inc.) - Utang jangka cendhak perusahaan|Utang jangka cendhak Actuate Therapeutics Inc ACTU|Kewajiban jangka cendhak perusahaan CTOR (Citius Oncology, Inc.)|tuhurabio.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan TARA (Protara Therapeutics, Inc.)|Fate Therapeutics Inc (FATE) - Utang jangka cendhak|WHWK - Utang jangka cendhak perusahaan|TCRX (TScan Therapeutics) - Tanggungan utang jangka cendhak perusahaan|CSBR: Utang jangka cendhak perusahaan|Utang jangka cendhak XBiotech (XBIT)|Kewajiban jangka cendhak perusahaan CVM|OSTX (OS Therapies Inc.) - Gedhene kewajiban jangka cendhak|Utang jangka cendhak perusahaan RADX|Gunggunge utang jangka cendhak artivabio.com|Utang jangka cendhak perusahaan ANL (Adlai Nortye)|VERU - Kewajiban jangka cendhak perusahaan|TPST: Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan XLO (Xilio Therapeutics, Inc.)|RENB: Utang jangka cendhak perusahaan|MURA (Mural Oncology) - Utang jangka cendhak perusahaan|KAPA (Kairos Pharma Limited) - Utang jangka cendhak perusahaan|OnKure (OKUR) - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan CytoMed Therapeutics (GDTC)|CRIS - Utang jangka cendhak|Utang jangka cendhak perusahaan Apollomics APLM|Gunggunge utang jangka cendhak Tharimmune Corporation (THAR)|Advanced Biomed Corp - Utang jangka cendhak perusahaan|genprex.com (GNPX) - Kewajiban jangka cendhak perusahaan|CLDI: Utang jangka cendhak perusahaan|SBFM - Gunggunge utang jangka cendhak|SLRX (Salarius) - Utang jangka cendhak perusahaan|Utang jangka cendhak Kitov Pharma PPBT|Utang jangka cendhak perusahaan American Oncology Network (AONC)|beigene.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan CKPT (Checkpoint Therapeutics, Inc.)|ELEV - Kewajiban jangka cendhak perusahaan|iCAD Corp - Utang jangka cendhak perusahaan|Utang jangka cendhak Ikena Oncology, Inc.|Notable Labs, Ltd. (NTBL) - Utang jangka cendhak perusahaan|VIRX - Gunggunge utang jangka cendhak|Kewajiban jangka cendhak perusahaan MOR|Tanggungan utang jangka cendhak perusahaan NAYA (NAYA Biosciences Inc)|Utang jangka cendhak perusahaan AAPGV